CRISPR Therapeutics AG (NASDAQ:CRSP) Receives $71.75 Average Target Price from Brokerages
Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the eighteen analysts that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and ten have given a buy rating to […]
More Stories
Pfizer Inc. (NYSE:PFE) Holdings Raised by Elevation Point Wealth Partners LLC
Elevation Point Wealth Partners LLC increased its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 15.9% in the 1st...
Dynamic Advisor Solutions LLC Cuts Holdings in Pfizer Inc. (NYSE:PFE)
Dynamic Advisor Solutions LLC lessened its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 9.6% in the first quarter,...
Brighton Jones LLC Cuts Stake in Kimberly-Clark Co. (NYSE:KMB)
Brighton Jones LLC lowered its stake in shares of Kimberly-Clark Co. (NYSE:KMB – Free Report) by 6.0% in the first...
Brighton Jones LLC Cuts Stake in Kimberly-Clark Co. (NYSE:KMB)
Brighton Jones LLC lowered its stake in shares of Kimberly-Clark Co. (NYSE:KMB – Free Report) by 6.0% in the first...
Brighton Jones LLC Cuts Stake in Kimberly-Clark Co. (NYSE:KMB)
Brighton Jones LLC lowered its stake in shares of Kimberly-Clark Co. (NYSE:KMB – Free Report) by 6.0% in the first...
Brighton Jones LLC Cuts Stake in Kimberly-Clark Co. (NYSE:KMB)
Brighton Jones LLC lowered its stake in shares of Kimberly-Clark Co. (NYSE:KMB – Free Report) by 6.0% in the first...